Neuroimaging of Opioid Phase (OPAL)
- NCT ID
- NCT05905419
- Registry status
- Recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- Duke University
- Conditions
- Chronic Pain, Opioid Use
Overview
ClinicalTrials.gov lists this study as Recruiting.
Official title: Neurobiological Consequences of Long-Term Opioid Therapy in the Brain and Spinal Cord
Enrollment: 140 participants (Estimated).
What is being studied
- Other: Opioid Phase
Who may be eligible
- Ages
- 18 Years to no maximum
- Sex
- Female
- Healthy volunteers accepted
- Yes
ClinicalTrials.gov lists the following eligibility criteria.
Study locations
1 study location is listed.
Recruiting site status is explicitly provided for 1 location; 1 is listed as Recruiting.
Countries: United States
- North Carolina, United States: 1
Sample of listed locations
- Duke University Medical Center — Durham, North Carolina, 27710, United States — Recruiting
Study details
- Start date
- June 1, 2023
- Primary completion date
- June 30, 2027
- Completion date
- June 30, 2027
- First posted
- June 15, 2023
- Collaborators
- National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH)
Source and update information
- Source
- ClinicalTrials.gov
- NCT ID
- NCT05905419
- Registry last updated
- June 3, 2026
- QualifiedStudies registry data refreshed
- October 2, 2026
- QualifiedStudies record fetched
- October 2, 2026
View NCT05905419 on ClinicalTrials.gov
Trial information can change. Confirm current study details with the study team or the registry.
About joining clinical research
Find clinical trials you may match with
QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.
Find clinical trials you may match with | Clinical trial FAQ